دورية أكاديمية

Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.

التفاصيل البيبلوغرافية
العنوان: Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.
المؤلفون: Matteo, Andrea Di, Lorenzis, Enrico De, Duquenne, Laurence, Nam, Jacqueline L, Garcia-Montoya, Leticia, Harnden, Kate, Chowdhury, Rahaymin, Wakefield, Richard J, Emery, Paul, Mankia, Kulveer
المصدر: Rheumatology; Aug2024, Vol. 63 Issue 8, p2213-2221, 9p
مصطلحات موضوعية: RISK assessment, RESEARCH funding, T-test (Statistics), RHEUMATOID arthritis, AUTOANTIBODIES, MUSCULOSKELETAL system diseases, FISHER exact test, LOGISTIC regression analysis, ULTRASONIC imaging, DESCRIPTIVE statistics, CHI-squared test, MANN Whitney U Test, KAPLAN-Meier estimator, LOG-rank test, ODDS ratio, DATA analysis software, CONFIDENCE intervals, SYMPTOMS
مستخلص: Objectives To investigate, in anti-CCP antibody–positive individuals with musculoskeletal symptoms but no clinical synovitis (CCP+ at-risk), the additional value of US for the prediction of inflammatory arthritis. Furthermore, to define a concise US protocol for feasible risk prediction. Methods Demographic and clinical data were collected in 417 CCP+ at-risk (Leeds CCP cohort) with a baseline US scan assessing synovitis and bone erosions in 36 joints, and a follow-up duration ≥24 months. Multivariable binary regression models for inflammatory arthritis development at 24 months evaluated routine clinical variables associated with inflammatory arthritis alone ('clinical' model) and combined with a 36-joint US scanning protocol ('clinical-US extended' model). A 'clinical-US short' model was also developed. Results At 24 months, 92/417 (22.1%) CCP+ at-risk developed inflammatory arthritis (median time 7 months, interquartile range 3–12). The 'clinical-US extended' model performed better than the 'clinical' model [area under the curve (AUC) 0.788 vs AUC 0.731, respectively, P  < 0.001] with an odds ratio for inflammatory arthritis development of 3.18 (95% CI 1.80–5.63) for US synovitis and 2.54 (95% CI 1.21–5.37) for bone erosions. The 'clinical-US short' model, which retained the wrists, knees and MTP5 joints, performed better (AUC 0.782) than the 'clinical' model (P  < 0.001) and similarly (difference in Akaike information criteria <2) to the 'clinical-US extended' model. Conclusions US provides valuable information for predicting progression to inflammatory arthritis in CCP+ individuals both alone and in addition to clinical variables. US synovitis was associated with a 3-fold increase risk of inflammatory arthritis development. A concise US protocol of six joints provides clinically feasible risk prediction in CCP+ at-risk. [ABSTRACT FROM AUTHOR]
Copyright of Rheumatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14620324
DOI:10.1093/rheumatology/kead570